Cyklokapron en es it fr

Cyklokapron Brand names, Cyklokapron Analogs

Cyklokapron Brand Names Mixture

  • No information avaliable

Cyklokapron Chemical_Formula


Cyklokapron RX_link

Cyklokapron fda sheet

Cyklokapron FDA

Cyklokapron msds (material safety sheet)

Cyklokapron MSDS

Cyklokapron Synthesis Reference

No information avaliable

Cyklokapron Molecular Weight

388.458 g/mol

Cyklokapron Melting Point

188.7 oC

Cyklokapron H2O Solubility

40 mg/L

Cyklokapron State


Cyklokapron LogP


Cyklokapron Dosage Forms

Capsules (300 mg) for oral administration; Suppositories (200 mg); Injectable (100 mg, 200 mg)

Cyklokapron Indication

For the treatment of postoperative nausea and vomiting and for nausea associated with gastroenteritis.

Cyklokapron Pharmacology

Trimethobenzamide is a novel antiemetic which prevents nausea and vomiting in humans. Its actions are unclear but most likely involves the chemoreceptor trigger zone (CTZ). In dogs pretreated with trimethobenzamide HCl, the emetic response to apomorphine is inhibited, while little or no protection is afforded against emesis induced by intragastric copper sulfate.

Cyklokapron Absorption

The relative bioavailability of the capsule formulation compared to the solution is 100%.

Cyklokapron side effects and Toxicity

Oral LD50 in mice is 1600 mg/kg.

Cyklokapron Patient Information

No information avaliable

Cyklokapron Organisms Affected

Humans and other mammals